Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
29m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
55m agoCPKC increases dividend by 17.5 percent
55m agoWaldencast announces conclusion of SEC investigation
56m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
56m agoF5 to Host Analyst and Investor Meeting on May 28, 2026

Devonian Health Group Inc

About

Devonian Health Group Inc (V:GSD) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 25 2026
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
Feb 19 2026
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
Feb 17 2026
Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
Feb 12 2026
Devonian reports additional molecular data from MASH liver study
Feb 10 2026
DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY

Financials

Revenue
CA$10.18 M
Market Cap
CA$33.37 M
EPS
-3.47

Community Chat

Ask AI

6ix6ixAIEvents